 Released: Jul 1, 2008
Expires: Jun 30, 2009
Type: PDF
The International Journal of Advances in Rheumatology, a CME/CPE/CNE-accredited educational program, systematically identifies, evaluates, and places into clinical context the most important recent studies into the science and medicine of rheumatoid diseases. It provides rapid access for busy specialists to a critical and clinically relevant review of the developments that...
|
- CME Credits/Hours: 2.00
- CPE Credits/Hours: 2.00
- CNE Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
Released: Jun 11, 2008
Expires: Jun 10, 2009
Type: PDF
Rheumatoid arthritis (RA) currently afflicts 1.3 million American adults. A progressive disease of the joints with a recognized autoimmune component, RA causes eventual loss of joint structure and function. The disease is also associated with serious extraarticular and comorbid disease, evidenced by studies identifying a 10-15 year shorter lifespan for patients with RA. RA...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
Released: Mar 2, 2008
Expires: Mar 1, 2009
Type: PDF
Each issue of the International Journal of Advances in Rheumatology will present carefully constructed, leading (review) articles, written by practicing
rheumatologists and developed to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editors-in-Chief,...
|
- CME Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
Released: Feb 19, 2008
Expires: Feb 19, 2009
Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- Credits/Hours:
- Cost: Free
-
System Requirements:
|
Released: Feb 19, 2008
Expires: Feb 19, 2009
Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
Released: Feb 19, 2008
Expires: Feb 19, 2009
Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
Released: Feb 19, 2008
Expires: Feb 19, 2009
Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
Released: Feb 19, 2008
Expires: Feb 19, 2009
Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
Released: Feb 19, 2008
Expires: Feb 19, 2009
Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- Credits/Hours:
- Cost: Free
-
System Requirements:
|
Released: Feb 15, 2008
Expires: Feb 14, 2009
Type: PDF
Rheumatology Highlights, a CME-accredited educational program, presents a carefully constructed report from a major international conference and is developed to equip readers with practical knowledge of the area under discussion. This newsletter is commissioned to support particular educational themes identified by the Editor-in-Chief, Editorial team and readers. This issue...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
Released: Nov 15, 2007
Expires: Nov 15, 2008
Type: PDF
Currently, three tumor necrosis factor (TNF) antagonists are approved for the treatment of patients with rheumatoid arthritis (RA): infliximab, etanercept, and adalimumab. Whilst, overall, TNF antagonists are well tolerated and have demonstrated a favorable risk–benefit profile, there are lingering concerns over their long-term safety. For example, data from clinical trials...
|
- CME Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
Released: Sep 19, 2007
Expires: Nov 9, 2008
Type: PDF
Rheumatoid arthritis (RA) afflicts 2.1 million Americans. A progressive disease of the joints with a recognized autoimmune component, RA is often associated with debilitating pain and stiffness, and eventual loss of joint function in many patients. In addition, RA may be associated with serious extraarticular disease, and significant comorbidities, best revealed by studies...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.20
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
Released: Nov 5, 2007
Expires: Nov 4, 2008
Type: PDF
Each issue of the International Journal of Advances in Rheumatology will present carefully constructed, leading (review) articles, written by practicing rheumatologists and developed to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editors-in-Chief, Editorial...
|
- CME Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
Released: Aug 1, 2007
Expires: Aug 31, 2008
Type: PDF
Each issue of the International Journal of Advances in Rheumatology will present carefully constructed, leading (review) articles, written by practicing rheumatologists and developed to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editors-in-Chief, Editorial...
|
- CME Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
Released: Sep 1, 2007
Expires: Aug 31, 2008
Type: PDF
Abstracts in Rheumatology, a CME-accredited educational program, presents a carefully constructed summary of a major international conference and is developed to equip readers with practical knowledge of the area under discussion. The comments are commissioned to support particular educational themes identified by the Editor-in-Chief and the...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
Released: Aug 23, 2007
Expires: Aug 23, 2008
Type: PDF
Rheumatoid arthritis (RA) afflicts 2.1 million Americans (www.niams.nih.gov). A progressive disease of the joints with a recognized autoimmune component, RA causes debilitating pain and stiffness, and eventual loss of joint function. By 10 years following diagnosis, greater than 50% of patients are no longer able to work, underscoring the...
|
- CME Credits/Hours: 2.00
- CPE Credits/Hours: 2.00
- CNE Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
Released: Aug 15, 2007
Expires: Aug 14, 2008
Type: PDF
Rheumatology Highlights, a CME-accredited educational program, presents a carefully constructed report from a major international conference and is developed to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editor-in-Chief, Editorial team and readers....
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
|
